Polyethylene Glycol 3350

CAS 25322-68-3 4 current recordsOther

Who holds supplier records for Polyethylene Glycol 3350? 4 organisations hold a current record for Polyethylene Glycol 3350: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (1) and China (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Polyethylene Glycol 3350: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/polyethylene-glycol-3350

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Polyethylene Glycol 3350. Country is the organisation's recorded country, not necessarily the manufacturing site.

India1China1Country not recorded for 2
Need Polyethylene Glycol 3350 sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Polyethylene Glycol 3350 is an osmotic laxative used to relieve occasional constipation. It retains water in the bowel, leading to softer stools and increased bowel movements.

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Osmotic Laxative
Mechanism of action
Osmotic Activity
Physiologic effect
Stimulation Large Intestine Fluid/Electrolyte Secretion

Therapeutic areas

Gastroenterology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Polyethylene Glycol 3350?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Polyethylene Glycol 3350: AVESTA PHARMA PVT LTD (India), BASF CORP, CLARIANT CHEMICALS (HUIZHOU) LTD (China) and PHARCOS SPECIALITY LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Polyethylene Glycol 3350 Drug Master Files are active?

AVESTA PHARMA PVT LTD (DMF 27419), BASF CORP (DMF 16946), CLARIANT CHEMICALS (HUIZHOU) LTD (DMF 32355) and PHARCOS SPECIALITY LTD (DMF 41320). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Polyethylene Glycol 3350 supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Polyethylene Glycol 3350?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.